nach oben

Pituitary

Erschienen in:

01.10.2014

Pituitary incidentalomas

verfasst von: George A. Scangas, Edward R. Laws Jr.

Erschienen in: Pituitary | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Incidentally discovered pituitary adenomas are more and more commonly encountered in endocrinology and neurosurgical practices. Often they present as difficult problems in management strategies. This review summarizes the latest evidence and opinions in a variety of settings in which incidental pituitary tumors are discovered, including subclinical pituitary tumor apoplexy.

Methods

A systematic literature review was accomplished using a spectrum of contemporary sources for information regarding pituitary incidentalomas.

Results

Up to date findings regarding epidemiology, definition of pituitary incidentaloma, patient evaluation, diagnostic studies, and management are presented.

Conclusions

Current experience from a multidisciplinary pituitary center is presented, with indications for treatment and longitudinal care of these challenging patients.

Costello RT (1936) Subclinical adenoma of the pituitary gland. Am J Pathol 12:205–215PubMedCentralPubMed

Freda PU, Beckers AM, Katznelson L, Molitch ME, Montori VM, Post KD et al (2011) Pituitary incidentaloma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96:894–904PubMedCrossRef

Molitch ME (2008) Nonfunctioning pituitary tumors and pituitary incidentalomas. Endocrinol Metab Clin North Am 37:151–171 xiPubMedCrossRef

Nammour GM, Ybarra J, Naheedy MH, Romeo JH, Aron DC (1997) Incidental pituitary macroadenoma: a population-based study. Am J Med Sci 314:287–291PubMedCrossRef

Vernooij MW, Ikram A, Tanghe HL et al (2007) Incidental findings on brain MRI in the general population. N Engl J Med 357:1821–1828PubMedCrossRef

Hall W, Luciano M, Doppman J et al (1994) Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med 120(10):817–820PubMedCrossRef

Famini P, Maya MM, Melmed S (2011) Pituitary magnetic resonance imaging for sellar and parasellar masses: ten year experience in 2,598 patients. J Clin Endocrinol Metabol 96(6):1633–1641CrossRef

Buurman H, Saeger W (2006) Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data. Eur J Endocrinol 154:753–758PubMedCrossRef

Kim J-H, Seo J-S, Lee B-W et al (2007) The characteristics of incidental pituitary microadenomas in 120 Korean forensic autopsy cases. J Korean Med Sci 22(Suppl.):S61–S65PubMedCentralPubMedCrossRef

10.

Auer RN, Alakija P, Sutherland GR (1996) Asymptomatic large pituitary adenomas discovered at autopsy. Surg Neurol 46:28–31PubMedCrossRef

11.

Parent AD, Bebin J, Smith RR (1981) Incidental pituitary adenomas. J Neurosurg 54:228–231PubMedCrossRef

12.

McComb DJ, Ryan N, Horvath E, Kovacs K (1983) Subclinical adenomas of the human pituitary. New light on old problems. Arch Pathol Lab Med 107:488–491PubMed

13.

Siqueira MG, Guembarovski AL (1984) Subclinical pituitary microadenomas. Surg Neurol 22:134–140PubMedCrossRef

14.

Bancos I, Natt N, Murad MH, Montori VM (2012) Evidence-based endocrinology: illustrating its principles in the management of patients with pituitary incidentalomas. Best Pract Res Clin Endocrinol Metab 26(1):9–19PubMedCrossRef

15.

Anagnostis P, Adamidou F, Polyzos S et al (2011) Pituitary incidentalomas: a single-centre experience. Int J Clin Pract 65(2):172–177PubMedCrossRef

16.

Arita K, Tominaga A, Sugiyama K, Eguchi K, Iida K, Sumida M et al (2006) Natural course of incidentally found nonfunctioning pituitary adenoma, with special reference to pituitary apoplexy during follow-up examination. J Neurosurg 104:884–891PubMedCrossRef

17.

Feldkamp J, Santen R, Harms E, Aulich A, Mödder U, Scherbaum WA (1999) Incidentally discovered pituitary lesions: high frequency of macroadenomas and hormone-secreting adenomas—results of a prospective study. Clin Endocrinol (Oxf) 51:109–113CrossRef

18.

Reincke M, Allolio B, Saeger W, Menzel J, Winkelmann W (1990) The ‘incidentaloma’ of the pituitary gland. Is neurosurgery required? JAMA 263:2772–2776PubMedCrossRef

19.

Sanno N, Oyama K, Tahara S, Teramoto A, Kato Y (2003) A survey of pituitary incidentaloma in Japan. Eur J Endocrinol 149:123–127PubMedCrossRef

20.

Fainstein Day P, Guitelman M, Artese R, Fiszledjer L, Chervin A, Vitale NM et al (2004) Retrospective multicentric study of pituitary incidentalomas. Pituitary 7:145–148 (Erratum in Pituitary 14:198, 2011)PubMedCrossRef

21.

Donovan LE, Corenblum B (1995) The natural history of the pituitary incidentaloma. Arch Intern Med 155:181–183PubMedCrossRef

22.

Aron D, Howlett T (2000) Pituitary incidentalomas. Endocrinol Metab Clin North Am 29(1):205–221PubMedCrossRef

23.

Freda PU, Post KD (1999) Differential Diagnosis of sellar masses. Endocrinol Metab Clin North Am 28:81–118PubMedCrossRef

24.

King JT Jr, Justice AC, Aron DC (1997) Management of incidental pituitary microadenomas: a cost-effectiveness analysis. J Clin Endocrinol Metab 82:3625–3632PubMed

25.

Molitch ME (1997) Pituitary incdientalomas. Endocrinol Metab Clin North Am 26:725–740PubMedCrossRef

26.

Molitch ME, Russell EJ (1990) The pituitary “incidentaloma”. Ann Intern Med 112:925–931PubMedCrossRef

27.

Jane JA and Laws ER (2013) www.endotext.org Chapter 16—Surgical treatment of pituitary adenomas. Updated May 15, 2013

28.

Molitch ME (1995) Clinical review 65. Evaluation and treatment of the patient with a pituitary incidentaloma. J Clin Endocrinol Metab 80:3–6PubMed

29.

Semple PL, Jane JA Jr, Laws ER Jr (2007) Clinical relevance of precipitating factors in pituitary apoplexy. Neurosurgery 61(5):956–961PubMedCrossRef

30.

Semple PL, Webb MK, de Villiers JC, Laws ER Jr (2005) Pituitary apoplexy. Neurosurgery 56(1):65–72PubMed

31.

Semple PL, de Villiers JC, Bowen RM, Lopes MBS, Laws ER Jr (2006) Pituitary apoplexy: do histological features influence the clinical presentation and outcome? J Neurosurg 104:931–937PubMedCrossRef

32.

Chanson P, Daujat F, Young J et al (2001) Normal pituitary hypertrophy as a frequent cause of pituitary incidentalomas: a followup study. J Clin Endocrinol Metab 86:3009–3015PubMedCrossRef

33.

Sivakumar W, Chamoun R, Nguyen V, Couldwell WT (2011) Incidental pituitary adenomas. Neurosurg Focus 31(6):E18PubMedCrossRef

34.

Howlett T, Como J, Aron D (2000) Management of pituitary incidentalomas. A survey of British and American endocrinologists. Endocrinol Metab Clin North Am 29(1):223–230PubMedCrossRef

35.

Ahmed S, Elsheikh M, Stratton I et al (1999) Outcome of transsphenoidal surgery for acromegaly and its relationship to surgical experience. Clin Endocrinol 50(5):561–567CrossRef

36.

Bates AS, Van’t Hoff W, Jones JM, Clayton RN (1993) An audit of outcome of treatment of acromegaly. Q J Med 86:293–299PubMed

37.

O’Brien T, O’Riordan DS, Gharib H, Scheithauer BW, Ebersold MJ, van Heerden JA (1996) Results of treatment of pituitary disease in multiple endocrine neoplasia, type I. Neurosurgery 39:273–279PubMedCrossRef

38.

Scheithauer BW, Laws ER Jr, Kovacs K, Horvath E, Randall RV, Carney JA (1987) Pituitary adenomas of the multiple endocrine neoplasia type I syndrome. Semin Diagn Pathol 4:205–211PubMed

39.

Randeva HS, Schoebel J, Byrne J, Esiri M, Adams CBT, Wass JA (1999) Classical pituitary apoplexy: clinical features management and outcome. Clin Endocrinol 51:181–188CrossRef

40.

Gruber A, Clayton J, Kumar S, Robertson I, Howlett TA, Mansell P (2006) Pituitary apoplexy: retrospective review of 30 patients- is surgical intervention always necessary? Br J Neurosurg 20:379–385PubMedCrossRef

41.

Dekkers OM, Hammer S, de Keizer RJ, Roelfsema F, Schutte PJ, Smit JW et al (2007) The natural course of non-functioning pituitary macroadenomas. Eur J Endocrinol 156:217–224PubMedCrossRef

42.

Fernández-Balsells MM, Murad MH, Barwise A, Gallegos-Orozco JF, Paul A, Lane MA et al (2011) Natural history of nonfunctioning pituitary adenomas and incidentalomas: a systematic review and metaanalysis. J Clin Endocrinol Metab 96:905–912PubMedCrossRef

43.

Nishizawa S, Ohta S, Yokoyama T, Uemura K (1998) Therapeutic strategy for incidentally found pituitary tumors (“pituitary incidentalomas”). Neurosurgery 43:1344–1350PubMed

44.

Igarashi T, Saeki N, Yamaura A (1999) Long-term magnetic resonance imaging follow-up of asymptomatic sellar tumors. Their natural history and surgical indications. Neurol Med Chir 39:592–599CrossRef

45.

Karavitaki N, Collison K, Halliday J et al (2007) What is the natural history of nonoperated, nonfunctioning pituitary adenomas? Clin Endocrinol 67:938–943CrossRef

46.

Oyama K, Sanno N, Tahara S et al (2005) Management of pituitary incidentalomas: according to a survey of pituitary incidentalomas in Japan. Semin Ultrasound CT MRI 26:47–50CrossRef

47.

Molitch ME (2009) Pituitary tumours: pituitary incidentalomas. Best Pract Res Clin Endocrinol Metab 23:667–675PubMedCrossRef

48.

Daly AF, Burlacu MC, Livadariu E et al (2007) The epidemiology and management of pituitary incidentalomas. Horm Res 68(suppl. 5):195–198PubMedCrossRef

Titel: Pituitary incidentalomas
verfasst von: George A. Scangas
Edward R. Laws Jr.
Publikationsdatum: 01.10.2014
Verlag: Springer US
Erschienen in: Pituitary / Ausgabe 5/2014
Print ISSN: 1386-341X
Elektronische ISSN: 1573-7403
DOI: https://doi.org/10.1007/s11102-013-0517-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Introduction

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2014

Characterization of pituitary cells targeted by antipituitary antibodies in patients with isolated autoimmune diseases without pituitary insufficiency may help to foresee the kind of future hypopituitarism

Nasally located ectopic ACTH-secreting pituitary adenoma (EAPA) causing Nelson’s syndrome: diagnostic challenges

Cerebrovascular complications and utilization of endovascular techniques following transsphenoidal resection of pituitary adenomas: a study of the Nationwide Inpatient Sample 2001–2010

GH secretion reserve in subclinical hypercortisolism

Adult mortality or morbidity is not increased in childhood-onset growth hormone deficient patients who received pediatric GH treatment: an analysis of the Hypopituitary Control and Complications Study (HypoCCS)